TAC1 and neoplasm: Through inhibiting the angiotensin-converting enzyme, ACEIs reduce the degradation of bradykinin and substance P [50–52], resulting in their accumulation in the lungs, stimulating tumour cell proliferation, increasing vascular permeability, and contributing to tumour cell metastasis [28, 53–55].